Records containing: Sickle Cell Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-15A Phase 1/2, Open-Label, Dose Escalating Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AB1 in Adult Patients With Sickle Cell Disease (SCD)
-
CLINICAL_TRIALS study results posted · 2026-09-16A Phase 1/2/3 Study to Evaluate the Safety and Efficacy of a Single Dose of Autologous CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (CTX001) in Subjects With Severe Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-08-25Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
-
CLINICAL_TRIALS study results posted · 2026-06-30Gerofit Exercise Intervention for Older Adults With Sickle Cell Disease (SICKLE-FIT Study)
-
CLINICAL_TRIALS study results posted · 2026-06-10A LOW-INTERVENTIONAL LONGITUDINAL STUDY OF AN ELECTRONIC SICKLE CELL DISEASE PATIENT REPORTED OUTCOMES IN ADULT PARTICIPANTS AGED ≥18 YEARS OF AGE ON AND OFF HYDROXYUREA
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-06-03Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
-
CLINICAL_TRIALS study results posted · 2026-04-29Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients With Symptomatic Sickle Cell Disease. (BMTCTN1507)
-
CLINICAL_TRIALS study results posted · 2026-04-28Closely Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation With TCRαβ+ T Cell and B Cell Depletion For Patients With Sickle Cell Disease and Thalassemia Major
-
CLINICAL_TRIALS study record update · 2026-04-27Sickle Cell Disease Stem Cell Mobilization and Apheresis Using Motixafortide
-
CLINICAL_TRIALS study record update · 2026-04-27Evaluation of the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase I/II Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-24School Readiness Intervention for Preschool Children With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-24A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-24A Global Phase 3, Randomised, Double-blind and Placebo-controlled Study Evaluating the Efficacy and Safety of Etavopivat in Adolescents and Adults With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-23Exploring Adherence Monitoring in Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-23Pilot Trial of Stimulant Treatment to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-23Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-23Evaluation of the Diagnostic Performance of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multicenter, Dose- Finding, Efficacy, and Safety Study of Tebapivat in Participants With Sickle Cell Disease
-
CLINICAL_TRIALS study record update · 2026-04-22Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)
-
CLINICAL_TRIALS study record update · 2026-04-21Pharmacogenetics and Model-Informed Optimisation of Hydroxyurea Therapy in Sickle Cell Disease Patients of Nigerian Descent
-
CLINICAL_TRIALS study record update · 2026-04-21American Thrombosis and Hemostasis Network ATHNdataset Registry
-
CLINICAL_TRIALS study record update · 2026-04-21Evaluation of the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
-
CLINICAL_TRIALS study record update · 2026-04-21Realizing Effectiveness Across Continents With Hydroxyurea: A Phase I/II Prospective Trial of Hydroxyurea for Children With Sickle Cell Anemia